<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Trieste_project_applications"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Trieste/project/applications">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Trieste/project/applications&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Trieste/project/applications&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Trieste/project/applications&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Trieste/project/applications" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Trieste/project/applications</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2012.igem.org</H3><DIV id="head"><TITLE>Team Trieste iGEM 2012</TITLE></DIV><DIV id="body"><DIV id="container"><DIV id="header"><DIV id="payoff">The Jolly JoCare<DIV>a safe probiotic platform for protein expression</DIV></DIV><UL id="navigation"><LI><A href="https://2012.igem.org/Team:Trieste">HOME</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/team">TEAM</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/team">Team</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/City&amp;Lab">City&amp;Lab</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/Team Gal">Team Gallery</A></LI></UL><LI><A href="https://2012.igem.org/Team:Trieste/project">PROJECT</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/project">Abstract</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/project/overview">Project Overview</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/project/applications">Applications</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/project/modeling">Modeling</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/project/mainres">Main Results</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/data">DATA</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/parts">PARTS</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/notebook">DIARY</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/notebook">Notebook</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/protocols">Protocols</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/safety">SAFETY</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/safety">Safety</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/survey">Safety Survey</A></LI><LI><A href="http://www.icgeb.org/~bsafesrv/" target="_blank">ICGEB Safety Unit</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/outreach">OUTREACH</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/outreach">Human Practice</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/outreach/press">Press</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/extra">EXTRA</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/extra">Attributions</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/extra/ach">Achievements</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/extra/aks">Acknowledgement</A></LI></DIV><DIV id="content"><H1 id="h1_lf" class="main_tit"><DIV>Application</DIV></H1><H1 id="h1_rt" class="main_tit"><DIV>More</DIV></H1><DIV id="box_main"><DIV class="box_contenuti"><P class="fancy">
		    The safe probiotic constructed here can be used to produce nutritious,
		    preventive or therapeutic molecules. For example, this <I> E.coli </I> can
		    express antitumorals, antibodies against different intestinal pathogens,
		    imunomodulators, antigens (recombinant proteins which act as mucosal
		    vaccine) which are important for the correct development of the immune
		    system etc. It can express also different enzymes as lactase or enzymes
		    needed to recreate the metabolic pathways to produce nutrients such
		    as vitamins.</P><P class="fancy">
		    To give a proof-of-concept, we have used our safe probiotic to deliver
		    to gut mucosa a neutralizing antibody (Ab 54.6)<SUP><A href="#sup1">[1]</A></SUP> against an emerging
		    Norovirus (NoV), one of the most common causes of gastroenteritis in the
		    world.<STRONG> To this end, we used a LPP-OmpA based cell display system<SUP><A href="#sup2">[2]</A></SUP> to
		    express the scFv (single chain fragment variable) format of the antibody
		    attached to the bacterial surface. According to the literature, scFvs
		    anchored to the bacterial surface can bind multiple viral particles
		    and protect efficiently against infection. The chosen scFv sequence,
		    which was already known to inhibit Norovirus (NoV) interaction with
		    cells, was inserted in frame downstream the LPP-OmpA sequence and
		    this construct was cloned under a constitutive promoter.</STRONG> LPP-OmpA is a
		    chimeric sequence having part of the major outer membrane lipoprotein
		    and an outer membrane porin OmpA fragment. This chimeric sequence acts
		    as a leader sequence and an anchor, it transports the scFv fused at its
		    C-terminus through the cytoplasm membrane into the periplasm, where the
		    scFv assumes the right conformation. OmpA portion then introduces itself
		    into the outer membrane displaying extracellularly its C terminus with
		    the Ab attached on.</P><STRONG>The anti-NoV antibody was also expressed as a SIP
		    (Small Immuno Protein) format, which contains the scFv fused to the CH3
		    domain of the heavy chain of human immunoglobulin A (IgA)</STRONG>. Since the
		    CH3 region is able to homodimerize, it should confer bivalent binding
		    properties to the anti-NoV scFv54.6. Secreted SIPs have the dual advantage
		    of being bivalent as full-length antibodies and being small as scFvs. They
		    have also been shown to have the potential to protect against enteric
		    infections when administered orally<SUP><A href="#sup3">[3]</A></SUP>. Eventually,
		    <STRONG>we planned to produce also the secreted versions of the anti-NoV SIP
		    54.6 and of the scFv 54.6</STRONG>. Both the scFv and the SIP sequences were
		    cloned downstream the pelB leader sequence. PelB drives proteins into the
		    periplasmic space, where it is cleaved off. The resulting proteins can
		    be released into the extracellular space by passing through porins. This
		    system can also be used for production of small, soluble molecules.
			<DIV class="footnotes"><H3>References</H3><P id="sup1">
							[1]: <STRONG>Recombinant norovirus-specific scFv inhibit virus-like particle binding to cellular ligands </STRONG>
							Khalil Ettayebi adn Michele E. Hardy
							Virology Journal, Jan. 2008, 5:21, doi:10.1186/1732-3422X-5-21
					</P><P id="sup2">
						[2]: <STRONG>Transport and anchoring of beta-lactamase to the external surface of Escherichia coli</STRONG>
						Joseph A. Francisco, Charles F. Eearhart, and George Georgiou 
						Proceedings of the National Academy of Sciences USA, Biochemistry, April 1992, Vol. 89, pp. 2713-2717
					</P><P id="sup3">
						[3]: <STRONG>An antibody derivative expressed from viral vectors passively immunizes pigs against transmissible gastroenteritis virus infection when supplied orally in crude plant extracts</STRONG>
						Wendy Monger, Josefa M. Alamillo, Isabel Sola, Yolande Perrin, Marco Bestagno, Oscar R. Burrone, Patricia Sabella, Joan Plana-Duran, Luis Enjuanes, Juan A. Garcia and George P. Lomonossoff 
						Plant Biotechnology Journal (2006) 4, pp. 623–631 doi: 10.1111/j.1467-7652.2006.00206.x
					</P></DIV></DIV></DIV><DIV id="box_right"><UL id="sub_menu"><LI><A href="https://2012.igem.org/Team:Trieste/project">Abstract</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/project/overview">Project Overview</A></LI><LI class="select"><A href="https://2012.igem.org/Team:Trieste/project/applications">Applications</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/project/modeling">Modeling</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/project/mainres">Main Results</A></LI></UL><DIV class="box_contacts"><H2>Contact us</H2><P>For other information, write to:</P><A href="mailto:igem2012@gmail.com" class="btn">igem2012@gmail.com</A><DIV class="social">               Follow us also:
			</DIV></DIV></DIV></DIV><DIV id="footer"><DIV id="box_footer">iGEM 2012 - For info: <A href="mailto:igem2012@gmail.com">igem2012@gmail.com</A></DIV></DIV></DIV></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2012.igem.org/Team:Trieste/project/applications">http://2012.igem.org/Team:Trieste/project/applications</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Trieste/project/applications" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Trieste/project/applications" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Trieste/project/applications&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Trieste/project/applications&amp;oldid=230261" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2012.igem.org:Privacy_policy" title="2012.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2012.igem.org:General_disclaimer" title="2012.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>